March 12, 2025: Washington, DC – Millions of Americans would be affected by the Trump administration’s attempts to shorten the Affordable Care Act (ACA) open enrollment period and eliminate the monthly enrollment option for low-income families.
March 7, 2025: Washington, DC – Next week, the National Consumers League (NCL) will join hundreds of consumer advocates and constituents from 45 states to urge lawmakers to support a strong and independent Consumer Financial Protection Bureau (CFPB). Since its creation in 2011, the CFPB has recovered more than $21 billion for consumers who have been harmed by corporate greed and fraud. Cutting the CFPB would leave millions of hard-working Americans vulnerable to scams and other illegal conduct.
March 5, 2025: Washington, DC – The National Consumers League (NCL) is calling on lawmakers to vote in favor of maintaining the Consumer Financial Protection Bureau’s (CFPB) larger participants rule, which establishes much-needed oversight of companies that offer services like digital wallets and payment apps—such as Zelle and Apple Pay—and ensures they are properly regulated. The rule protects consumers, making sure that all forms of payment, whether provided by traditional banks or nonbank companies, are secure and trustworthy.
February 27, 2025: Washington, DC – Today, the U.S. Senate Commerce committee approved Steven Bradbury for Deputy Secretary of the U.S. Department of Transportation, sending his nomination to the Senate floor. The National Consumers League (NCL) is urging Bradbury to commit to using the position to support critical safety and consumer protection initiatives at DOT.
February 26, 2025: Washington, DC – The National Consumer League (NCL) expresses strong support for the Crypto ATM Fraud Prevention Act introduced by Senator Dick Durbin (D-IL). This critical legislation aims to protect consumers from rising scams involving cryptocurrency ATMs. The minimal regulation of these machines, combined with the anonymity and irreversibility of cryptocurrency transactions, makes crypto ATMs a preferred tool for scammers.
February 25, 2025: Washington, DC – Today, The National Consumers League (NCL) proudly joins the American Vehicle Owners Alliance (AVOA) as a founding member. This new coalition brings together eight members who will work together to ensure that vehicle owners—not just manufacturers—have full access and control over the data generated by their vehicles. AVOA will advocate for policies protecting consumers’ property rights, fostering competition, and preventing unnecessary and burdensome restrictions on owner’s access to vehicle-generated data.
February 25, 2025: Washington, DC – The National Consumers League (NCL) is proud to announce its support for the PBM Accountability Project’s letter, which has been shared with the U.S. House Energy & Commerce Health Subcommittee ahead of their hearing on February 26, 2025. The PBM Accountability Project calls for urgent reform of the Pharmacy Benefit Manager (PBM) industry to increase transparency, reduce prescription drug costs, and provide relief to consumers and patients across the nation.
February 24, 2025: Washington, DC – The National Consumers League (NCL) is deeply concerned about President Trump’s executive order that purports to reduce federal overreach by focusing enforcement resources on regulations explicitly authorized by the Constitution and federal statutes. This order seeks to dismantle what the administration views as an “overbearing and burdensome administrative state,” emphasizing the restoration of the constitutional separation of powers.
February 21, 2025: Washington, DC – The National Consumer League (NCL) is proud to join Congresswoman Rosa DeLauro and other supporters in advocating for the reintroduction of the American Family Act. This landmark legislation seeks to make the expanded and improved Child Tax Credit (CTC) permanent. This critical policy helps lift families out of poverty and provides economic stability for millions of American households. As original supporters of this initiative, NCL continues to emphasize the importance of providing financial security to families, especially those facing economic hardship.
February 21, 2024: Washington, DC – The National Consumers League (NCL) is greatly disappointed by the Trump administration’s efforts to eliminate vital energy efficiency standards for household appliances, as referenced in Project 2025. These standards, which have been established over the past few decades, have played an integral role in reducing energy consumption, lowering utility bills, and helping consumers make sustainable choices. Rolling back these standards would directly harm consumers and the environment, leaving us more vulnerable in the face of the climate crisis.
The work of the National Consumers League is making a difference in people’s lives across the country. Meet some of the consumers touched by our programs.
Read about NCL’s impact
Paige, 55, a Nashville wife and mother of two, answered an employment ad for secret shoppers. Before sending payment to the scammers, she reached out to NCL.
Read about NCL’s impact
A grease fire flared up in Decklan’s kitchen. As his family scrambled and panicked, fearing that the whole house might erupt in flames, Decklan remained calm. He hurried over to the pantry, grabbed some baking soda, and dumped it on the fire quickly extinguishing the blaze.
Read about NCL’s impact
Cincinnati resident Charles, 45, lost his computer business — and health insurance— during a time of economic downturn. A diabetic, Charles was now unable to afford his medication. He stopped taking it which made him seriously ill and put his life at risk.
Read about NCL’s impact
Jeremy is a fast-food worker who has been employed at a number of Chipotle restaurants in New York City. When he was just 20 years old, he took part in an NCL research project that revealed that management practices within the fast food chain were putting workers—and food safety for customers—at risk.
Read about NCL’s impact
By Sally Greenberg, NCL Executive Director
While the COVID-19 pandemic has led to hardship for all Americans, it is clear that people of color have been disproportionately burdened. Across the health care continuum, addressing this disparity has become part of the broader conversation about the history of systemic racism and the underlying social determinants of health that negatively affect the mental, physical, and economic health of individuals and entire communities.
The pandemic has underscored persistent health disparities, and there is growing recognition that representation in research and clinical trials can have a profound impact on health outcomes. A lack of representation from racially and ethnically diverse groups in research and clinical trials have typically led to gaps in data, missing the opportunity to assess the full impact of various treatments and drugs across a range of populations. The collection and use of real-world research and data to inform the potential use, risks, and benefits of medical products and treatments can ultimately lead to better health outcomes, particularly for those who have been underrepresented in the past.
Existing efforts to improve inclusion
Efforts to expand diversity and representation in medical research are underway in Congress. Policymakers are encouraging the incorporation of Real World Evidence (RWE) in drug development through the recent Cures 2.0 draft legislation released by Reps. Diana Degette (D-CO-1) and Fred Upton (D-MI-6). While the status quo limits us from effectively reaching underserved populations, the proposed legislation would allow studies that include RWE for some drugs after they have been approved. At the heart of this issue is a growing appreciation that the same therapy can affect different populations in different ways, which is why Cures 2.0 supports collecting data that more accurately reflects the unique experiences and needs of patients across diverse populations.
Recognizing the potential for RWE in maternal health
The lack of representative research in the field of maternal health is undeniable, and its implications are staggering. The dismal state of maternal care in the United States reflects how our health care system has failed women of color, including by not adequately studying treatment options to prevent maternal morbidity and mortality. The need for RWE is clear when you consider the persistent disparities in health outcomes that plague minority communities.
Preterm birth and its disproportionate impact on women of color is a stark illustration of the need to make progress on representative research in maternal health. Preterm birth is the second-largest contributor to infant death in America today. Despite the tremendous physical, emotional, and financial toll that preterm birth continues to take on our country — disproportionately so on women and families of color — not enough therapeutic tools currently exist to prevent it.
Today, “17P,” the only FDA-approved treatment to help reduce the likelihood of spontaneous, recurrent preterm birth in the United States is at-risk of being withdrawn from the market in all its forms, including the branded product and five generic versions. Unfortunately there is conflicting evidence from two different clinical trials, one representative of a diverse U.S. population and another studied in a largely white population in Europe. It’s not a straightforward comparison. If 17P is withdrawn, the women most affected by preterm birth, predominantly women of color, would be left without an FDA-approved treatment option.
The FDA is considering the path forward, including additional data collection through leveraging RWE from past patient use. The success of the first (approval) trial for 17P in the impacted communities signals the importance of RWE. Continued access to 17P is, at its core, a matter of health equity. Black women must not yet again be left vulnerable to a system that historically has overlooked them.